Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: II. behavioural characterisation of RG-15-Reference-Cited by-同舟云学术

Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: II. behavioural characterisation of RG-15

Published:2008-06-12 Issue:5 Volume:378 Page:529-539
ISSN:0028-1298
Container-title:Naunyn-Schmiedeberg's Archives of Pharmacology
language:en
Short-container-title:Naunyn-Schmied Arch Pharmacol

Author:

Gyertyán István,Sághy Katalin,Laszy Judit,Elekes Ottilia,Kedves Rita,Gémesi Larisza I.,Pásztor Gabriella,Zájer-Balázs Mária,Kapás Margit,Ágai Csongor Éva,Domány György,Kiss Béla,Szombathelyi Zsolt

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00210-008-0311-x.pdf

Reference41 articles.

1. Accili D, Fishburn CS, Drago J, Steiner H, Lachowicz JE, Park BH, Gauda EB, Lee EJ, Cool MH, Sibley DR, Gerfen CR, Westphal H, Fuchs S (1996) A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. Proc Natl Acad Sci USA 93:1945–1949

2. Ahlenius S (1999) Clozapine: dopamine D1 receptor agonism in the prefrontal cortex as the code to decipher a Rosetta stone of antipsychotic drugs. Pharmacol Toxicol 84:193–196

3. Coward DM (1992) General pharmacology of clozapine. Brit J Psychiatry Suppl 17:5–11

4. Gurevich EV, Joyce JN (1999) Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons. Neuropsychopharmacology 20:60–80

5. Gyertyán I, Sághy K (2004) Effects of dopamine D3 receptor antagonists on spontaneous and agonist-reduced motor activity in NMRI mice and Wistar rats: comparative study with nafadotride, U 99194A and SB 277011. Behav Pharmacol 15:253–262

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cariprazine Augmentation in Treatment-Resistant Bipolar Depression: Data from a Retrospective Observational Study;Current Neuropharmacology;2024-08

2. Eficacia, seguridad y tolerabilidad de cariprazina en el trastorno depresivo mayor: Una revisión sistemática y aspectos prácticos;Psiquiatría Biológica;2024-08

3. Transaminase-catalysis to produce trans-4-substituted cyclohexane-1-amines including a key intermediate towards cariprazine;Communications Chemistry;2024-04-18

4. Cariprazine augmentation in patients with treatment resistant unipolar depression who failed to respond to previous atypical antipsychotic add-on. A case-series;Frontiers in Psychiatry;2023-11-27

5. Evaluation of the Effect of Cariprazine on Memory and Cognition in Experimental Rodent Models;International Journal of Environmental Research and Public Health;2022-11-09